跳至主要内容
临床试验/NCT06891053
NCT06891053Enrolling By Invitation不适用

Studio TIARA: Alessitimia ed Emicrania Cronica

Azienda Sanitaria Locale di Alessandria1 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2022年5月30日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
350
试验地点
1
主要终点
Degree of alexithymia

研究概览

简要总结

The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity of the clinical phenotype of migraine, favoring its chronicization), in an analysis adjusted for psychiatric comorbidity (for anxiety and depression, potentially influencing migraine chronicization) and for personalogical factor represented by apathy.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
12 Years 至 65 Years(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Diagnosis of episodic migraine with or without aura, chronic migraine and/or MOH according to ICHD-3 2018 criteria;
  • Patients aged 12-65 years;
  • Female patients

排除标准

  • Ongoing major depressive episode;
  • Comorbidities for major internal diseases (hepatopathy, nephropathy, heart failure, etc.);
  • Alcohol or substance abuse disorder (eoin, cocaine, cannabis, hallucinogens);
  • Language barrier;
  • Low cultural/cognitive level;
  • No informed consent.

结局指标

主要结局

Degree of alexithymia

时间窗: In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval

Independent variable measured as a score on the TAS-20 scale

Migraine frequency

时间窗: In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval

次要结局

  • Number of "drug days" in patients diagnosed with MOH(In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval)
  • Degree of alessithymia in patients diagnosed with MOH(In 3 periods of 30 days each (3 months), which make up the 90-day observation time interval)

研究者

发起方
Azienda Sanitaria Locale di Alessandria
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验